Name/Surname
Fanghui ZHAO, Professor
Affiliation
Deputy Director and Professor of Department of Cancer
Epidemiology, National Cancer Center, Cancer Hospital,
Chinese Academy of Medical Sciences and Peking Union
Medical College, Beijing, People's Republic of China.
Screening Group (SCR), IARC, Dr Rengaswamy
Sankaranarayanan.
Cancer Epidemiology; Cancer Prevention and early detection
2007-2010: Ph.D, Peking Union Medical College (PUMC),
Beijing, The People's Republic of China.
1998-2001: M.P.H., Peking Union Medical College, Beijing,
The People's Republic of China.
1993-1998: Medical Diploma, Norman Bethune University of
Medical Sciences, Changchun, Jilin Province, China
Exploration of Appropriate Cervical Cancer Screening Program
Models for China
• Huang H, Hu XF, Zhao FH (Correspondence author),
Garland SM, Bhatla N, Qiao Y L. Estimation of Cancer
Burden Attributable to Infection in Asia. J Epidemiol. 2015
Nov 5;25(10):626-38.
• Zhu FC, Chen W, Hu YM, Hong Y, Li J, Zhang X, Zhang
YJ, Pan QJ, Zhao FH (Correspondence Author), Yu JX,
Zhang YS, Yang X, Zhang CF, Tang H, Zhang H, Lebacq
M, David MP, Datta SK, Struyf F, Bi D, Descamps D.
Efficacy, immunogenicity and safety of the HPV-16/18
AS04-adjuvanted vaccine in healthy Chinese women aged
18-25 years: Results from a randomised controlled trial. Int
J Cancer. 2014 Dec 1;135(11):2612-22.
• Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang
YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H,
Durand C, Datta SK, Struyf F, Bi D. Baseline prevalence
and type distribution of human papillomavirus in healthy
Chinese women aged 18-25 years enrolled in a clinical trial.
Int J Cancer. 2014 Dec 1;135(11):2604-11.
• Zhao FH, Jeronimo JA, Qiao YL, Schweizer J, Chen W,
Valdez M, Lu P, Zhang X, Kang LN, Bansil P, Paul P,
Mahoney C, Berard-Bergery M, Bai P, Peck R, Li J, Chen
F, Stoler MH, Castle PE. An Evaluation of Novel, LowerCost Molecular Screening Tests for Human Papillomavirus
in Rural China. Cancer Prev Res. 2013 Sep;6(9):938-48.
• Chang IJ, Huang R, He W, Zhang SK, Wang SM, Zhao
FH(Correspondence author), Smith JS, Qiao YL. Effect
of an educational intervention on HPV knowledge and
vaccine attitudes among urban employed women and
IARC Host Group
Speciality
Academic Degrees
Programme at IARC
Selected Publications
•
•
•
•
•
•
•
female undergraduate students in China: a cross-sectional
study. BMC Public Health. 2013 Oct 2;13:916.
Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang
ZZ, Li M, Ren ZF, Zhao FH(Correspondence author),
Qiao YL*. Perceptions and acceptability of HPV
vaccination among parents of young adolescents: a
multicenter national survey in China. Vaccine. 2013 Jul
11;31(32):3244-9.
Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang
QM, Wu RF, Li CQ, Wei LH, Xu AD, Zhang WH, Pan QJ,
Zhang X, Belinson JL, Sellors JW, Smith JS, Qiao YL,
Franceschi S. Prevalence of HPV and cervical
intraepithelial neoplasia in China: A pooled analysis of 17
population-based Studies. Int J Cancer. 2012 Dec
15;131(12):2929-38.
Zhao FH, Tiggelaar SM, Hu SY, Xu LN, Hong Y, Niyazi
M, Gao XH, Ju LR, Zhang LQ, Feng XX, Duan XZ, Song
XL,Wang J, Yang Y, Li CQ, Liu JH, Liu JH, Lu YB, Li L,
Zhou Q, Liu JF, Zhao N, Schmidt JE, Qiao YL. A Multicenter Survey of Age of Sexual Debut and Sexual Behavior
in Chinese Women: Suggestions for Optimal Age of HPV
Vaccination in China. Cancer Epidemiology. 2012 36: 384–
390.
Zhao FH, Lewkowitz A, Chen F, Lin MJ, Hu SY, Zhang X,
Pan QJ, Li CQ, Ma JF, Li SM, Smith JS, Belinson JL, Qiao
YL, Castle PE. A pooled analysis of self-collected
cervicovaginal specimen and HPV DNA testing
performance as primary screening test for cervical cancer in
rural China. J Natl Cancer Inst. 2012 Feb 8;104(3):178-88.
(with commentary).
Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL,
Sellors JW, Franceschi S, Qiao YL, Castle PE; on behalf of
Cervical Cancer Screening Group in China. Performance of
high-risk HPV DNA testing as a primary screen for cervical
cancer: a pooled analysis of individual patient data from 17
population-based studies from China. Lancet Oncol. 2010
Dec;11(12):1160-1171 (Fast-track with commentary).
Zhao FH, Forman MR, Belinson J, Shen YH, Graubard BI,
Patel AC, Rong SD, Pretorius RG, Qiao YL. Risk factors
for HPV infection and cervical cancer among unscreened
women in a high-risk rural area of China. Int J Cancer.
2006 Jan 15;118(2):442-8.
Castle PE, Zhao FH. Population Effectiveness, Not Efficacy,
Should Decide Who Gets Vaccinated Against Human
Papillomavirus via Publicly Funded Programs. Editorial
commentary, the Journal of Infectious Diseases
2011;204:335–37.)
Short background
Professor Zhao is Deputy Director and Professor at the Dept. of
Cancer Epidemiology, Cancer Institute/Hospital, Chinese
Academy of Medical Sciences (CICAMS). She is also the
mentor of PhD students in Peking Union Medical College, the
primary mentor for NIH Fogarty and Fulbright Scholars in
China, as well as the mentor and initiator of Chicago University
D & A China Bridge Fellowship Program in China.
Professor Zhao received her Medical Diploma from Norman
Bethune University of Medical Sciences, her PhD degree in
Epidemiology from Peking Union Medical College. She has
worked as a visiting scholar during 2003-2004 and 2013-2014
in Division of Cancer Prevention and Control, Center for Global
Health, Division of Cancer Epidemiology & Genetics at
National Cancer Institute, National Institutes of Health
(NCI/NIH).
Her research interests include Epidemiological research on
cancers notably on cervical cancer and breast cancer;
implementation and methodological research in screening and
early detection of cancer; primary prevention and intervention
to cancers; pubic health promotion and health policy
Over the past 18 years, Professor Zhao has been involved in a
serial research in cervical cancer prevention including A)
Etiology and epidemiologic research on human papillomavirus
(HPV) and cervical cancer; B) Clinical trials on cervical cancer
screening technologies and research on strategies; C) Costeffectiveness and health economic analysis of strategies on
cervical cancer screening; D) HPV Vaccine clinical trial and
vaccines implementation studies. Her research findings have
great scientific and practical significances for cervical cancer
epidemiology, etiology and prevention in China.
Professor Zhao has received a dozen of research grants
including the National Science Fund for Excellent Young
Scholars; the National High-tech R&D Program of China (863
Program); the National Key Technology Research and
Development Program of China during the 11th Five-Year Plan;
and a grant from Bill and Melinda Gates Foundation as well.
She has published more than 100 peer reviewed articles,
monographs and book chapters in Chinese and English, some of
them published on the Journals of ,and with high impact factors.
Professor Zhao serves as Research Committee Chair, Asia
Oceania Research Organization on Genital Infections and
Neoplasia (AOGIN); Secretary-general & Member of the
Standing Committee of Cancer Epidemiology Committee,
Chinese Anti-Cancer Association (CACA); Deputy Secretarygeneral & Member of the Standing Committee of Chinese
Society of Colposcopy & Cervical Pathology (CSCCP) ;
Member of Epidemiology Committee, Chinese Association of
Preventive Medicine; Member of maternal and child health
industry branch of the National Health Industry Enterprise
Management Association; Member of the innovation alliance of
young scientists in the Chinese Academy of Medical Sciences;
Secretary of National Cervical Cancer Prevention Experts
Committee, Ministry of Health, China.
Professor Zhao has the honor of national excellent doctoral
dissertation, and also won several national scientific awards and
international Scholarship awards including the Science and
Technology Advanced Awards of Ministry of Education and
Beijing Municipal Government; Higher Education Institutions
Awards for Excellent Teachers; Chinese medical science and
Technology Award; Science and technology award of Chinese
Preventive Medicine Association, etc.
Institutional webpage:
https://dce.cicams.ac.cn/EPI/en/content/fanghui-zhao
Personal webpage:
http://www.aacr.com.cn/info.asp?call=39